Literature DB >> 26370108

hTERT promotes the invasion of gastric cancer cells by enhancing FOXO3a ubiquitination and subsequent ITGB1 upregulation.

Changjiang Hu1, Zhenghong Ni2, Bo-Sheng Li1, Xin Yong1, Xin Yang1, Jian-Wei Zhang1, Dan Zhang1, Yong Qin1, Meng-Meng Jie1, Hui Dong1,3, Song Li4, Fengtian He2, Shi-Ming Yang1.   

Abstract

BACKGROUND AND AIMS: Human telomerase reverse transcriptase (hTERT) plays an important role in cancer invasion, but the relevant mechanism is not well known. This study aims to investigate the role and mechanism of hTERT in gastric cancer metastasis.
DESIGN: Proteomics analysis, qPCR and western blotting were used to screen for hTERT-regulated candidate molecules in gastric cancer invasion. Chromatin immunoprecipitation (ChIP) qPCR was performed to identify the binding sites of hTERT at the regulatory region of the integrin β1 (ITGB1) gene. ChIP assays were further applied to elucidate the transcription factors that bound to the regulatory region. The interactions between hTERT and the transcription factors were tested by co-immunoprecipitation (Co-IP) and glutathione S-transferase (GST) pull-down experiments. Moreover, the revealed pathway was verified in tumour-bearing nude mice and human gastric cancer tissues.
RESULTS: ITGB1 was identified as a downstream gene of hTERT, and there were two hTERT-binding regions within this gene. hTERT alleviated the binding of forkhead box O3 (FOXO3a) to FOXO3a binding element (+9972∼+9978), but it enhanced the binding of forkhead box M1 (FOXM1) to FOXM1 binding element (-1104∼-1109) in ITGB1 gene. Importantly, FOXO3a played a major role in hTERT-induced ITGB1 expression, and the hTERT/murine double minute 2 (MDM2) complex promoted the ubiquitin-mediated degradation of FOXO3a. Moreover, hTERT increased ITGB1 expression in xenograft gastric cancer, and the level of hTERT was positively correlated with that of ITGB1 in human gastric cancer tissues.
CONCLUSIONS: The hTERT/MDM2-FOXO3a-ITGB1 pathway markedly contributes to hTERT-promoted gastric cancer invasion, suggesting that this pathway might be a novel target for the prevention and treatment of gastric cancer metastasis. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/.

Entities:  

Keywords:  EXTRACELLULAR MATRIX; GASTRIC CANCER; MOLECULAR CARCINOGENESIS; MOLECULAR MECHANISMS; MOLECULAR ONCOLOGY

Mesh:

Substances:

Year:  2015        PMID: 26370108     DOI: 10.1136/gutjnl-2015-309322

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  41 in total

1.  Integrin β1 is a critical effector in promoting metastasis and chemo-resistance of esophageal squamous cell carcinoma.

Authors:  Zhipeng Xu; Li Zou; Gang Ma; Xiaowei Wu; Furong Huang; Tingting Feng; Suqing Li; Qingfeng Lin; Xiaoting He; Zhihua Liu; Xiufeng Cao
Journal:  Am J Cancer Res       Date:  2017-03-01       Impact factor: 6.166

2.  Genomic and epigenomic EBF1 alterations modulate TERT expression in gastric cancer.

Authors:  Manjie Xing; Wen Fong Ooi; Jing Tan; Aditi Qamra; Po-Hsien Lee; Zhimei Li; Chang Xu; Nisha Padmanabhan; Jing Quan Lim; Yu Amanda Guo; Xiaosai Yao; Mandoli Amit; Ley Moy Ng; Taotao Sheng; Jing Wang; Kie Kyon Huang; Chukwuemeka George Anene-Nzelu; Shamaine Wei Ting Ho; Mohana Ray; Lijia Ma; Gregorio Fazzi; Kevin Junliang Lim; Giovani Claresta Wijaya; Shenli Zhang; Tannistha Nandi; Tingdong Yan; Mei Mei Chang; Kakoli Das; Zul Fazreen Adam Isa; Jeanie Wu; Polly Suk Yean Poon; Yue Ning Lam; Joyce Suling Lin; Su Ting Tay; Ming Hui Lee; Angie Lay Keng Tan; Xuewen Ong; Kevin White; Steven George Rozen; Michael Beer; Roger Sik Yin Foo; Heike Irmgard Grabsch; Anders Jacobsen Skanderup; Shang Li; Bin Tean Teh; Patrick Tan
Journal:  J Clin Invest       Date:  2020-06-01       Impact factor: 14.808

3.  Fatty acid-induced CD36 expression via O-GlcNAcylation drives gastric cancer metastasis.

Authors:  Mingzuo Jiang; Nan Wu; Bing Xu; Yi Chu; Xiaowei Li; Song Su; Di Chen; Wenjiao Li; Yanting Shi; Xiaoliang Gao; Haohao Zhang; Zhao Zhang; Wei Du; Yongzhan Nie; Jie Liang; Daiming Fan
Journal:  Theranostics       Date:  2019-07-09       Impact factor: 11.556

4.  LncRNA HULC triggers autophagy via stabilizing Sirt1 and attenuates the chemosensitivity of HCC cells.

Authors:  H Xiong; Z Ni; J He; S Jiang; X Li; J He; W Gong; L Zheng; S Chen; B Li; N Zhang; X Lyu; G Huang; B Chen; Y Zhang; F He
Journal:  Oncogene       Date:  2017-02-06       Impact factor: 9.867

5.  Upregulation of h-TERT and Ki-67 in ectopic endometrium is associated with recurrence of endometriosis.

Authors:  Jie Luo; Zhimin Song; Tao Zhang; Ketan Chu; Jingyi Li; Jianhong Zhou; Jun Lin
Journal:  J Zhejiang Univ Sci B       Date:  2022-02-15       Impact factor: 3.066

6.  Hypoxia promotes pancreatic cancer cell migration, invasion, and epithelial-mesenchymal transition via modulating the FOXO3a/DUSP6/ERK axis.

Authors:  Hua Zhao; Wei Chen; Yi Zhu; Jianying Lou
Journal:  J Gastrointest Oncol       Date:  2021-08

7.  hTERT Promotes CRC Proliferation and Migration by Recruiting YBX1 to Increase NRF2 Expression.

Authors:  Chunli Gong; Huan Yang; Sumin Wang; Jiao Liu; Zhibin Li; Yiyang Hu; Yang Chen; Yu Huang; Qiang Luo; Yuyun Wu; En Liu; Yufeng Xiao
Journal:  Front Cell Dev Biol       Date:  2021-05-17

8.  Isorhapontigenin (ISO) inhibits EMT through FOXO3A/METTL14/VIMENTIN pathway in bladder cancer cells.

Authors:  Ning Zhang; Xiaohui Hua; Huailu Tu; Jingxia Li; Zhuo Zhang; Costa Max
Journal:  Cancer Lett       Date:  2021-07-28       Impact factor: 9.756

Review 9.  β1 Integrins as Therapeutic Targets to Disrupt Hallmarks of Cancer.

Authors:  Anne-Florence Blandin; Guillaume Renner; Maxime Lehmann; Isabelle Lelong-Rebel; Sophie Martin; Monique Dontenwill
Journal:  Front Pharmacol       Date:  2015-11-24       Impact factor: 5.810

10.  Inhibition of peritoneal metastasis of human gastric cancer cells by dextran sulphate through the reduction in HIF-1α and ITGβ1 expression.

Authors:  Yuanyi Xu; Xiu Jin; Yunning Huang; Jianda Dong; Honghong Wang; Xiaofei Wang; Xiangmei Cao
Journal:  Oncol Rep       Date:  2016-03-18       Impact factor: 3.906

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.